| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2023 | AMPH Amphastar Pharmaceuticals, Inc. | Zhou Rong59 | EVP, Production Center | Sell | 5,000 | $48.24 | $241,200.00 | -5.4% | +9.1% | -14.1% | |
| Jun 13, 2023 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 7,586,207 | $0.03 | $220,000.00 | +6.8% | - | - | |
| Jun 12, 2023 | JNJ Johnson & Johnson | Wengel Kathryn E61 | EVP, Chief To And Risk Officer | Sell | 12,465 | $160.00 | $1,994,400.00 | -15.9% | +1.7% | -8.2% | |
| Jun 9, 2023 | PLSH Panacea Life Sciences Holdings, Inc. | Buttorff Leslie | CEO | Buy | 3,000 | $0.43 | $1,297.50 | +0.2% | - | - | |
| Jun 8, 2023 | ALKS Alkermes Plc. | Laurencin Cato T59 | Director | Sell | 2,638 | $31.85 | $84,020.30 | -26.1% | -6.4% | -24.2% | |
| Jun 8, 2023 | PCRX Pacira Biosciences, Inc. | Kronenfeld Mark A. | Director | Sell | 15,000 | $37.04 | $555,600.00 | -45.6% | -5.7% | -22.8% | |
| Jun 7, 2023 | ALKS Alkermes Plc. | Laurencin Cato T59 | Director | Sell | 2,800 | $31.50 | $88,200.00 | -27.2% | -6.0% | -22.2% | |
| Jun 7, 2023 | PCRX Pacira Biosciences, Inc. | Reinhardt Max79 | President, Rest Of World | Sell | 2,153 | $38.42 | $82,710.15 | -3.5% | -7.4% | -22.4% | |
| Jun 7, 2023 | PCRX Pacira Biosciences, Inc. | Williams Kristen Marie76 | Chief Administrative Officer | Sell | 2,658 | $38.42 | $102,110.10 | -5.8% | -7.4% | -22.4% | |
| Jun 7, 2023 | PCRX Pacira Biosciences, Inc. | Reinhart Charles A. III64 | Chief Financial Officer | Sell | 2,607 | $38.40 | $100,105.79 | -3.7% | -7.4% | -22.4% | |
| Jun 7, 2023 | PCRX Pacira Biosciences, Inc. | Stack David M67 | CEO And Chairman | Sell | 10,384 | $38.41 | $398,885.47 | -3.2% | -7.4% | -22.4% | |
| Jun 7, 2023 | PCRX Pacira Biosciences, Inc. | McLoughlin Dennis64 | Chief Customer Officer | Sell | 2,071 | $38.42 | $79,560.18 | -2.6% | -7.4% | -22.4% | |
| Jun 7, 2023 | PCRX Pacira Biosciences, Inc. | Slonin Jonathan72 | Chief Clinical Officer | Sell | 961 | $38.42 | $36,918.61 | -1.3% | -7.4% | -22.4% | |
| Jun 7, 2023 | HIMS Hims & Hers Health, Inc. | Baird Melissa | Chief Operating Officer | Sell | 18,266 | $9.10 | $166,211.47 | -2.1% | -24.8% | +135.5% | |
| Jun 7, 2023 | PCRX Pacira Biosciences, Inc. | Ellis Ronald J. Jr. | Chief Strategy Officer | Sell | 2,276 | $38.42 | $87,435.10 | -3.5% | -7.4% | -22.4% | |
| Jun 7, 2023 | PCRX Pacira Biosciences, Inc. | Winston Roy68 | Chief Medical Officer | Sell | 3,636 | $38.42 | $139,680.29 | -4.1% | -7.4% | -22.4% | |
| Jun 7, 2023 | PCRX Pacira Biosciences, Inc. | Riker Lauren Bullaro76 | Senior Vice President, Finance | Sell | 1,207 | $38.42 | $46,368.52 | -3.0% | -7.4% | -22.4% | |
| Jun 7, 2023 | PCRX Pacira Biosciences, Inc. | Gaugler Daryl67 | Chief Operating Officer | Sell | 3,052 | $38.52 | $117,570.61 | -4.3% | -7.4% | -22.4% | |
| Jun 6, 2023 | HIMS Hims & Hers Health, Inc. | Dudum Andrew48 | Chief Executive Officer | Sell | 71,933 | $9.13 | $657,014.44 | -15.7% | -25.0% | +136.7% | |
| Jun 6, 2023 | BIOE Bio Essence Corp | Yan Yin | Chief Executive Officer | Buy | 5,000,000 | $0.50 | $2,500,000.00 | +35.7% | - | - | |
| Jun 6, 2023 | PCRX Pacira Biosciences, Inc. | Molloy Anthony74 | Chief Lgl &Compliance Officer | Sell | 6,788 | $38.46 | $261,058.51 | -18.3% | -11.1% | -22.8% | |
| Jun 5, 2023 | PCRX Pacira Biosciences, Inc. | Brege Laura62 | Director | Sell | 600 | $38.74 | $23,244.00 | -5.9% | -9.8% | -20.8% | |
| Jun 5, 2023 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 5,820,106 | $0.03 | $162,962.97 | +5.5% | - | - | |
| Jun 5, 2023 | PCRX Pacira Biosciences, Inc. | Hastings Paul J77 | Director | Sell | 580 | $38.34 | $22,236.62 | -8.1% | -9.8% | -20.8% | |
| Jun 5, 2023 | HIMS Hims & Hers Health, Inc. | Baird Melissa | Chief Operating Officer | Sell | 9,133 | $8.89 | $81,201.50 | -2.1% | -23.0% | +132.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.